USPTO serial 99638535
NEXUS GLOBAL GROUP SCIENCE
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMILLAN, CHRISTOPHER J
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with NEXUS GLOBAL GROUP SCIENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chicago, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Gryzlo
Matthew J. Gryzlo Barnes & Thornburg LLPOne North Wacker Drive, Suite 4400Chicago, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business strategy development services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consultation and management regarding marketing activities and launching of new products; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Consulting services in the field of medical product approval for commercial purposes; Marketing consulting; Marketing advisory services; Digital marketing services; Creative marketing plan development services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Market research and market intelligence services; Competitive intelligence services; Business consulting in the field of clinical trials, namely, providing publication plans for others to share clinical trial results, scientific research, and therapeutic innovations in peer-reviewed journals or conferences; Abstracting services in the nature of extracting and summarizing information from clinical trials and case study records for clients to relay medical and scientific information at congresses; Advising on the graphic design of posters for medical and scientific congresses; technical writing services comprising of foundational scientific documents used to support publication efforts relating to pharmaceuticals; technical writing services comprising of manuscripts submitted to medical journals | ACTIVE | — |
| 041 | Arranging and conducting of conferences and symposia in the field of medical science; Consultancy relating to arranging and conducting of congresses; Consultancy relating to arranging and conducting of conferences; Arranging, conducting, and organization of seminars, lecture presentations and symposiums in the field of healthcare and pharmaceuticals for use by others in their internal training; Arranging and conducting of seminars and workshops in the field of pharmaceutical research; Arranging and conducting of training seminars in the field of pharmaceutical research; Providing classes, seminars, workshops, presentations and retreats in the field of pharmaceutical development | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Technical consulting in the field of pharmaceutical studies; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the field of pharmaceutical research and development; Software development and product development consulting in the field of healthcare; graphic design services; Development of digital codes, digital platforms and digital programs for others for therapeutic areas in the nature of digital and creative medical affairs assets | ACTIVE | — |
| 044 | Clinical medical consultation services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 29, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 29, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2026 | NWAP | NEW APPLICATION ENTERED | — |